Aller au contenu principal
2026 conference-abstract

1156 Myelopathic Versus Non-Myelopathic Cervical Patients: Different Value Propositions for ACDF Across Disability Levels

0Citations signalées — pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés

Résumé fourni par la source

INTRODUCTION: Previous research in anterior cervical discectomy and fusion (ACDF) has established that patients with severe preoperative neck disability derive greater value from surgery when compared to mildly disabled patients. However, these analyses treated preoperative diagnosis as a confounder rather than exploring potential interaction effects. METHODS: We analyzed 429 patients who underwent ACDF between 2017-2022. Using time-driven activity-based costing, we calculated total intraoperative costs for each procedure. Neck Disability index (NDI) was measured preoperatively and at 3-months postoperatively. Operative Value index (OVI), defined as percent NDI improvement per $1,000 spent, was our metric for surgical value. We performed multivariable regression with interaction terms while controlling for age, sex, BMI, comorbidities, smoking status, number of levels fused, location, and surgeon. RESULTS: After adjusting for all confounders, we found a significant interaction between preoperative NDI and myelopathy status (p = 0.004). For myelopathic patients, higher preoperative NDI strongly predicted better value (B-coefficient: 0.34, p < 0.001). In contrast, for non-myelopathic patients, this relationship was not significant (p = 0.22). Additionally, myelopathic patients with minimal disability had worse outcomes per dollar spent than nonmyelopathic patients with similar disability (OVI: -3.2 vs +2.4). This pattern reversed for severe-to-complete disability, where myelopathic patients demonstrated superior value (OVI: 9.4 vs 5.8). CONCLUSIONS: Myelopathic and non-myelopathic patients exhibit opposing cost-effectiveness patterns across disability levels, a finding that persists after adjustment for multiple confounders. Myelopathic patients demonstrate significantly increasing value with greater disability while non-myelopathic patients achieve substantial positive value regardless of baseline disability severity. This fundamental interaction challenges current selection paradigms for value-based spine surgery initiatives and suggests the need for pathology-specific criteria when evaluating ACDF candidates for bundled payment models.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
1156 Myelopathic Versus Non-Myelopathic Cervical Patients: Different Value Propositions for ACDF Across Disability Levels
Date Crossref
01/04/2026
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Sujets associés

Cervical and Thoracic MyelopathyMusculoskeletal pain and rehabilitationSpine and Intervertebral Disc Pathology

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.